Assessment of HER2 status in breast cancer - why, when and how?

Author： Dowsett M.   Cooke T.   Ellis I.   Gullick W.J.   Gusterson B.   Mallon E.   Walker R.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.36, Iss.2, 2000-01, pp. : 170-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of HER2 status on distant recurrence in early stage breast cancer

By Hess Kenneth  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 449-455

Springer Publishing Company

Access to resources Recommend Favorite

Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue

By Park In  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 125-128

Springer Publishing Company

Access to resources Recommend Favorite

Promoter methylation status of the FHIT gene and Fhit expression: Association with HER2/neu status in breast cancer patients

By            

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2270-2278

Spandidos Publications

Access to resources Recommend Favorite

Immunohistochemical determination of her2 expression in breast cancer from core biopsy specimens: a reliable predictor of her2 status of the whole tumor

By Mueller-Holzner E.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 13-19

Springer Publishing Company

Access to resources Recommend Favorite

HER2 status in a population-derived breast cancer cohort: discordances during tumor progression

By Wilking Ulla  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 553-561

Springer Publishing Company

Access to resources Recommend Favorite